首页>
外国专利>
TREATMENT REGIMEN FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBITORS USING THE MCL-1 INHIBITOR ALVOCIDIB
TREATMENT REGIMEN FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBITORS USING THE MCL-1 INHIBITOR ALVOCIDIB
展开▼
机译:使用MCL-1抑制剂ALVOCIDIB对BCL-2抑制剂不敏感的癌症的治疗方案
展开▼
页面导航
摘要
著录项
相似文献
摘要
Methods for treating BCL-2 inhibitor-resistant cancer in subjects using an MCL-1 inhibitor as well as compositions associated with the same are disclosed.
展开▼